Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01799148
Other study ID # AIRACOS
Secondary ID AIRACOS-CANARY I
Status Completed
Phase N/A
First received February 23, 2013
Last updated January 19, 2015
Start date November 2011
Est. completion date November 2014

Study information

Verified date January 2015
Source Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Contact n/a
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Observational [Patient Registry]

Clinical Trial Summary

The objectives of this study are: 1) To determine whether patients with acute coronary syndrome, the level of environmental exposure to particulate air pollutants in the week prior to admission, are related to concentrations of inflammatory molecules and oxidative stress. 2) To investigate whether the level of environmental exposure is an independent prognostic factor in terms of overall and cardiovascular mortality, myocardial infarction or unstable angina at 30 days, 6 and 12 months.


Recruitment information / eligibility

Status Completed
Enrollment 307
Est. completion date November 2014
Est. primary completion date July 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Patients with acute coronary syndrome

Exclusion Criteria:

- Infectious process and / or local or systemic inflammation in the 15 days before admission.

- Thyrotoxicosis.

- Neoplasms - or any other disease that seriously compromise the prognosis of life and / or generate a systemic inflammatory response.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Particulate air pollutants
We will determined the average concentrations of different sizes of particulate matter from 1 day or up to 7 days prior to admission in patients with acute coronary syndrome.

Locations

Country Name City State
Spain Hospital Universitario de Canarias La Laguna Santa Cruz de Tenerife

Sponsors (1)

Lead Sponsor Collaborator
Fundación Canaria Rafael Clavijo para la Investigación Biomédica

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Other Impact of air pollution on inflammation, oxidative stress and 1-year prognosis in patients hospitalized for acute coronary syndrome: During the evolution of these patients, after 30 days, 6 and 12 months will recorded major adverse cardiovascular events. It also will quantify the exposure of air pollutant particles in all patients included, at 30 days, 6 and 12 months. 1 year Yes
Primary Impact of air pollution on inflammation, oxidative stress and 1-year prognosis in patients hospitalized for acute coronary syndrome. A single center, cohort of consecutive patients admitted with diagnosis of acute coronary syndrome in the cardiology unit of a tertiary hospital, which will quantify the exposure of particulate air pollutants 24 hours a day 7 days earlier prior to admission. Also be determined inflammatory molecules and oxidative stress in admission. 7 days Yes
Secondary Impact of air pollution on inflammation, oxidative stress and 1-year prognosis in patients hospitalized for acute coronary syndrome. During the evolution of these patients, after 30 days, 6 and 12 months will recorded major adverse cardiovascular events. It also will quantify the exposure of air pollutant particles in all patients included, at 30 days, 6 and 12 months. 1 year Yes
See also
  Status Clinical Trial Phase
Recruiting NCT01090336 - Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) N/A